Nouscom: New hire for operationsSwiss oncology expert Nouscom has appointed Marina Udier Blagovic as its Chief Operating Officer. The position has been newly created to drive all aspects of business operations and business develop … more ➔
Crescendo Biologics: Finance proCambridge-based drug discovery company Crescendo Biologics Ltd has named Theodora Harold its Chief Financial Officer. She has held this position in several early stage and growing biotechs. more ➔
Nordic Nanovector: New on boardOslo-based Nordic Nanovector has elected Joanna Horobin to its board as Non-executive Board Director. She replaces Renee Tannenbaum who stepped down from the board for personal reasons. more ➔
Curevac: In command of financeGerman mRNA company Curevac AG has appointed Pierre Kemula as Chief Financial Officer. Kemula joins Curevac from medtech firm Pixium Vision, where he was also responsible for financial activities. more ➔
Laurels for stem cell groundbreakerThe Royal Swedish Academy of Sciences has awarded the Tobias Prize 2016 to stem cell researcher David Bryder of Lund University for his groundbreaking hematopoietic stem cell discoveries. more ➔
Prothena: Filling in for a friendDublin-based protein immunotherapy developer Prothena has appointed Gene Kinney as its new President and Chief Executive Officer. Kinney has also been appointed to Prothena’s Board of Directors. more ➔
Immunicum: Doctor takes the leadSwedish immuno-oncology play Immunicum AB has appointed Carlos de Sousa as its new CEO. Most recently, de Sousa worked as Chief Business Offer at Danish Zealand Pharma. more ➔
TxCell: Board ahoyImmunotherapy maker TxCell SA has appointed gene therapy expert Olivier Danos to its newly founded Scientific Advisory Board. Danos serves as Senior Vice President of Cell and Gene Therapy at Biogen … more ➔
GlaxoSmithKline: Insider AppointmentSix months ago, Andrew Witty, long-time CEO of Britains largest drug maker GlaxoSmithKline, announced he would retire in 2017. Now, GSK has named Emma Walmsley from inside the company as his successor. more ➔
Making a profitGerman molecular diagnostics specialist GNA Biosolutions GmbH has appointed Frank Krieg-Schneider as its Managing Director and CEO. Krieg-Schneider holds a PhD in molecular genetics from Mainz University … more ➔
